Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)
Close on Nov 18, 2026Market cap $3.16MP/E –Yield –
Mangoceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Mangoceuticals's price to sales ratio was 11.4× on Nov 11, 2026, against 33.0× a year earlier. Over the last 3 years it ranged from 5.3× to 48.7×, with a median of 12.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.4× | −10.6 |
| 2025 | Dec 31, 2025 | 22.0× | +15.2 |
| 2024 | Dec 31, 2024 | 6.8× | – |
See a number that looks wrong?